Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrotic disease characterized by a progressive decline in lung function with a median survival of 3–5 years after diagnosis. The course of disease is highly variable and unpredictable, often punctuated by episodes of acute respiratory failure, known...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Swati, Luckhardt, Tracy R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213901/
https://www.ncbi.nlm.nih.gov/pubmed/32440226
http://dx.doi.org/10.2147/DHPS.S224007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213901/
https://www.ncbi.nlm.nih.gov/pubmed/32440226
http://dx.doi.org/10.2147/DHPS.S224007

Ejemplares similares